Diamine β 2 adrenergic receptor agonists

Details Diamine β 2 adrenergic receptor agonists Diamine β 2 adrenergic receptor agonists

2005-06-02

2008-07-22

Davis, Brian J (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C564S360000, C514S309000, C514S653000

Reexamination Certificate

active

07402673

ABSTRACT:
The invention provides novel β2adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with β2adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.

REFERENCES:
patent: 3775477 (1973-11-01), Diana
patent: 3875233 (1975-04-01), Bastian et al.
patent: 3944611 (1976-03-01), Smith
patent: 4021485 (1977-05-01), Schromm et al.
patent: 4730008 (1988-03-01), Skidmore et al.
patent: 4853381 (1989-08-01), Finch et al.
patent: 4894219 (1990-01-01), Baker et al.
patent: 4992474 (1991-02-01), Skidmore et al.
patent: 5223614 (1993-06-01), Schromm et al.
patent: 5434304 (1995-07-01), Trofast et al.
patent: 5750701 (1998-05-01), Beeley et al.
patent: 6268533 (2001-07-01), Gao et al.
patent: 6362371 (2002-03-01), Moran et al.
patent: 6541669 (2003-04-01), Moran et al.
patent: 6576793 (2003-06-01), Moran et al.
patent: 6593497 (2003-07-01), Choi et al.
patent: 6653323 (2003-11-01), Moran et al.
patent: 6670376 (2003-12-01), Moran et al.
patent: 6747043 (2004-06-01), Moran et al.
patent: 6759398 (2004-07-01), Biggadike
patent: 2002/0019378 (2002-02-01), Angell et al.
patent: 2002/0022625 (2002-02-01), Walland et al.
patent: 2003/0229058 (2003-12-01), Moran et al.
patent: 2004/0157830 (2004-08-01), Biggadike et al.
patent: 2004/0180876 (2004-09-01), Biggadike et al.
patent: 2004/0242890 (2004-12-01), Coe et al.
patent: 2005/0113411 (2005-05-01), Linsell et al.
patent: 849 794 (1977-04-01), None
patent: 1158082 (1963-11-01), None
patent: 0 196 849 (1986-10-01), None
patent: 0 233 686 (1987-08-01), None
patent: 0147 719 (1989-07-01), None
patent: 1040724 (1966-09-01), None
patent: 52-83379 (1977-07-01), None
patent: 52-83619 (1977-07-01), None
patent: WO 01/42193 (2001-06-01), None
patent: WO 03/024439 (2003-03-01), None
patent: WO 03/042164 (2003-05-01), None
patent: WO 03/072539 (2003-09-01), None
patent: WO 2004/016578 (2004-02-01), None
patent: WO 2004/016601 (2004-02-01), None
patent: WO 2004/037768 (2004-05-01), None
patent: WO 2004/039766 (2004-05-01), None
Database CAPLUS on STN, Acc. No. 1949:19862, Niederl et al., Journal of Organic Chemistry (1949), 14, p. 27-30 (abstract).
Bompart et al., “Synthesis of new β-blocking analogs of bevantolol”, Annales Pharmaceutiques Francaises, vol. Date 1984, 42(6), pp. 537-545 (1985) (In French with English abstract).
Bompart et al., “Synthesis of new β-blocker analogs of bevantolol or alprenolol”, Annales Pharmaceutiques Francaises, vol. Date 1987, 45(5), pp. 379-387 (1988) (In French with English abstract).
Deyrup et al., “Structure-affinity profile of 8-hydroxycarbostyril-based agonists that dissociate slowly from the Beta2-adrenoceptor”, Naunyn-Schmiedeberg's Arch Pharmacol (1999) 359:168-177.
Isogaya et al., “Binding Pockets of the β1- and β2-Adrenergic Receptors for Subtype-Selective Agonists”), Molecular Pharmacology, vol. 56, pp. 875-885 (1999).
Milecki et al., “Carbostyril Derivatives Having Potent β-Adrenergic Agonist Properties”, J. Med. Chem, (1987), 30, 1563-1566.
Yokoi et al., “The Development of a Radioimmunoassay for Formoterol”, Life Sciences, (1983) vol. 33, No. 17, pp. 1665-1672.
Yoshizaki et al., “Sympathomimetic Amines Having a Carbostyril Nucleus”, J. Med. Chem., (1976), vol. 19, No. 9, pp. 1138-1142.
Batra et al., “Studies in antiparasitic agents: Part 15-Synthesis of 4-phenyl-1-(2-substituted-ethyl)imidazolidin-2-ones as structural analogs of levamisole metabolite and potential leishmanicidal agents”, Indian Journal of Chemistry, vol. 29B, pp. 855-858 (Sep. 1990).
Large et al., “β-Adrenergic blocking agents. 19. 1-phenyl-2-[[(substituted-amido)alkyl]amino]ethanols”, Journal of Medicinal Chemistry, vol. 23, pp. 112-117 (1980).
Niederl et al., “Studies in Diaryldiaminoalkanedios”, Journal of Organic Chemistry, 14, pp. 27-30.

Affiliated with

Also associated with

Rating

Diamine β 2 adrenergic receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diamine β 2 adrenergic receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diamine β 2 adrenergic receptor agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3971378